CITIUS ONCOLOGY INC (CTOR) Stock Balance Sheet
NASDAQ:CTOR • US17331Y1091
Current stock price
0.675 USD
+0.02 (+2.27%)
At close:
0.6443 USD
-0.03 (-4.55%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.30M | 3.92M | 32.80K | 289.20K | 0.00 | |||
| Receivables | 4.05M | N/A | N/A | N/A | N/A | |||
| Inventories | 22.64M | 22.29M | 8.27M | N/A | N/A | |||
| Other Current Assets | 3.16M | 1.33M | 25.50K | 88.20K | 2.69M | |||
| Total Current Assets | 37.15M | 27.54M | 58.20K | 377.30K | 2.69M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | N/A | N/A | 72.57M | 67.81M | N/A | |||
| Intangibles | 72.83M | 73.40M | 73.40M | 40.00M | 40.00M | |||
| Total Non-Current Assets | 72.83M | 73.40M | 72.57M | 67.81M | 40.00M | |||
| TOTAL ASSETS | 109.97M | 100.94M | 72.62M | 68.19M | 42.69M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 1.32M | 0.00 | 0.00 | |||
| Accrued Expenses | 4.52M | 4.09M | 380.90K | 31.80K | 1.06M | |||
| Accounts Payable | 10.45M | 13.23M | 3.71M | 1.29M | 92.30K | |||
| Other Current Liabilities | 29.74M | 32.16M | 344.90K | 19.50M | 4.69M | |||
| Total Current Liabilities | 44.71M | 49.49M | 2.05M | 31.80K | 5.85M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.80M | 3.80M | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.05M | 2.79M | 1.73M | 1.15M | 576.00K | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | N/A | N/A | |||
| Total Non-Current Liabilities | 6.85M | 6.59M | 0.00 | 0.00 | 576.00K | |||
| TOTAL LIABILITIES | 51.56M | 56.08M | 2.05M | 31.80K | 6.42M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -69.57M | -64.04M | -1.99M | 345.30K | -5.43M | |||
| Additional Paid In Capital | 127.98M | 108.90M | 85.41M | 43.66M | 41.69M | |||
| Common Shares | 8.50K | 8.40K | 72.57M | 67.81M | 6.80K | |||
| Shares Outstanding | 84.80M | 83.51M | 8.94M | 9.02M | 71.30M | |||
| Tangible Book Value per Share | -0.17 | -0.34 | 7.89 | 7.56 | -0.05 | |||
| Total Shareholders' Equity | 58.41M | 44.87M | 70.58M | 68.16M | 36.27M | |||
| TOTAL LIABILITIES AND EQUITY | 109.97M | 100.94M | 72.62M | 68.19M | 42.69M | |||
| Statistics | ||||||||
| Debt/Equity | 0.07 | 0.08 | N/A | N/A | N/A | |||
| Current Ratio | 0.83 | 0.56 | 0.03 | 11.86 | 0.46 | |||
| Return On Assets (ROA) | -21.49% | -24.53% | -29.12% | -18.62% | -12.73% | |||
| Return On Equity (ROE) | -40.46% | -55.19% | -29.97% | -18.63% | -14.98% | |||
All data in USD , ROIC based on taxRate of 0.21